4 ms·
Indeed, here here. As manufacturing capacity ramps up, and cost approaches $1-$5/month/person, it is an antidote against an economy wired to profit off of miswi
by toomuchtodo 2y ago
Indeed, here here. As manufacturing capacity ramps up, and cost approaches $1-$5/month/person, it is an antidote against an economy wired to profit off of miswired reward centers. Success is comin'. Healthier humans, less spending on poor nutrition, lower healthcare costs and improved health at scale. There is even robust evidence that GLP-1 agonists reduce addictive consumption of alcohol, nicotine, and opioids [1] [2].
It's the next metformin imho (cost to benefit ratio). We should be scaling up production like it's a war effort.
[1] https://news.ycombinator.com/item?id=40558601 https://news.ycombinator.com/item?id=40558601 (citation)
[2] https://news.ycombinator.com/item?id=40357197 https://news.ycombinator.com/item?id=40357197 ("u/comova: 1. GLP-1 drugs appear to dramatically reduce addictive drive across substances. 2. GLP-1 drugs can reach vastly more patients than existing medications and they have positive mental health benefits for anxiety and depression. 3. This is our first ever opportunity to make a big dent in the addiction crisis, which kills 770,000 people a year between opioids, cigarettes, and alcohol.")
- oigursh 2y agoI stopped binge drinking as a side-effect of semaglutide. I'm down 20kg and don't feel like shit all the time.
- deleted 2y ago[deleted]
- pixl97 2y agoHeh this drug sounds like an economy destroyer, companies are hooked on selling addiction and this is breaking the cycle.
- pfdietz 2y agoThere are multiple GLP-1 agonists on the market (five approved by the FDA for glycemic control, two of those also for weight loss) so I expect competition to drive down prices.
- toomuchtodo 2y agoAn interesting fact is that as long as there is a shortage of a compound, pharmacies can make a version using compounding. If demand always outstrips supply, compounding will be permitted. https://kffhealthnews.org/news/article/glp1-compounding-pharmacies-wegovy-zepbound-copycat-drugs-shortages/ https://kffhealthnews.org/news/article/glp1-compounding-phar...
- consteval 2y ago> miswired reward centers I wish we'd finally start calling obesity food addiction. It's an addiction that we've allowed to be economically viable, no different than alcohol and tobacco.